Form 4 for IMRX Immuneering Corp
Accepted 2025-09-30 00:00:00 ET · period of report 2025-09-29 · accession 0001790340-25-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2025-09-29 | IMRX | Feinberg Peter | Dir | P - Purchase | $7.18 | +5,000 | 141.8K | +4% | +$35.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-29 | P | A | 5,000 | $7.18 | 141,766 | D | — | — |